Steward Partners Investment Advisory’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9K | Hold |
8,826
| – | – | ﹤0.01% | 2927 |
|
|
2025
Q1 | $18.9K | Hold |
8,826
| – | – | ﹤0.01% | 2831 |
|
|
2024
Q4 | $21.4K | Hold |
8,826
| – | – | ﹤0.01% | 2757 |
|
|
2024
Q3 | $21.5K | Hold |
8,826
| – | – | ﹤0.01% | 2635 |
|
|
2024
Q2 | $22.7K | Hold |
8,826
| – | – | ﹤0.01% | 2469 |
|
|
2024
Q1 | $25.8K | Buy |
+8,826
| New | +$25.8K | ﹤0.01% | 2412 |
|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$2.18K | – | 3368 |
|
|
2023
Q1 | $2.18K | Hold |
1,000
| – | – | ﹤0.01% | 3003 |
|
|
2022
Q4 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 2470 |
|
|
2022
Q3 | $6K | Sell |
1,000
-1,000
| -50% | -$6K | ﹤0.01% | 2711 |
|
|
2022
Q2 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 2563 |
|
|
2022
Q1 | $17K | Hold |
2,000
| – | – | ﹤0.01% | 2449 |
|
|
2021
Q4 | $29K | Sell |
2,000
-500
| -20% | -$7.25K | ﹤0.01% | 2164 |
|
|
2021
Q3 | $55K | Buy |
2,500
+1,000
| +67% | +$22K | ﹤0.01% | 1840 |
|
|
2021
Q2 | $20K | Sell |
1,500
-60,000
| -98% | -$800K | ﹤0.01% | 5104 |
|
|
2021
Q1 | $625K | Buy |
61,500
+60,000
| +4,000% | +$610K | 0.01% | 803 |
|
|
2020
Q4 | $6K | Buy |
+1,500
| New | +$6K | ﹤0.01% | 2471 |
|
|
2020
Q3 | – | Sell |
-1,000
| Closed | -$4K | – | 2816 |
|
|
2020
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 2334 |
|
|
2020
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 2227 |
|
|
2019
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 2244 |
|
|
2019
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 2367 |
|
|
2019
Q2 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 2363 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$1K | – | 1714 |
|
|
2018
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 2510 |
|
|
2018
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 2238 |
|
|
2018
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 2151 |
|
|
2017
Q4 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 1710 |
|